|
|
|
Volumn 35, Issue 3, 1998, Pages 261-268
|
|
Recombinant human thrombopoietin: Clinical experience and in vivo biology
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
MEGAKARYOCYTE DEVELOPMENT FACTOR;
RECOMBINANT MEGAKARYOCYTE DEVELOPMENT FACTOR;
RECOMBINANT THROMBOPOIETIN;
UNCLASSIFIED DRUG;
APHERESIS;
BONE MARROW CELL;
CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
DOSE RESPONSE;
DRUG SAFETY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MEGAKARYOCYTE;
META ANALYSIS;
PRIORITY JOURNAL;
REVIEW;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
THROMBOCYTOPOIESIS;
ACUTE DISEASE;
ANTINEOPLASTIC AGENTS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIA;
RECOMBINANT PROTEINS;
THROMBOCYTOPENIA;
THROMBOPOIETIN;
|
|
EID: 0031843498
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (33)
|
|
References (31)
|
